1. Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
   Rien Ritawidya et al, 2023, Advanced Pharmaceutical Bulletin CrossRef
2. Glucose-Functionalized Liposomes for Reducing False Positives in Cancer Diagnosis
   Chen Tzror-Azankot et al, 2021, ACS Nano CrossRef
3. Genetic Risk Score for Prostate Cancer in the Romanian Population
   null null et al, 2019, ROMANIAN BIOTECHNOLOGICAL LETTERS CrossRef
4. Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
   Patrycja Guzik et al, 2021, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
5. Utilization of nanotechnology in targeted radionuclide cancer therapy: monotherapy, combined therapy and radiosensitization
   Noha Anwer Bayoumi et al, 2021, Radiochimica Acta CrossRef
6. Review of extremity dosimetry in nuclear medicine
   Robert Kollaard et al, 2021, Journal of Radiological Protection CrossRef
7. PROSPECTS FOR THE DEVELOPMENT OF NUCLEAR MEDICINE IN THE REPUBLIC OF KAZAKHSTAN: REACTOR ISOTOPES OF RARE EARTH ELEMENTS FOR THERAPY
   A. N. Gurin et al, 2022, NNC RK Bulletin CrossRef
8. LC–MS/MS Bioanalysis of Radioligand Therapeutic Drug Candidate for Preclinical Toxicokinetic Assessment
   Yunlin Fu et al, 2023, Analytical Chemistry CrossRef
9. Review: Production of nuclear medicine radioisotopes with ultra-intense lasers
   Zhanliang Sun, 2021, AIP Advances CrossRef